| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 7.81e-05 | 2 | 177 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | N-acetylgalactosamine-6-sulfatase activity | 7.81e-05 | 2 | 177 | 2 | GO:0043890 | |
| GeneOntologyMolecularFunction | N-acetylgalactosamine-4-sulfatase activity | 7.81e-05 | 2 | 177 | 2 | GO:0003943 | |
| GeneOntologyCellularComponent | microvillus | 8.32e-05 | 123 | 176 | 7 | GO:0005902 | |
| Domain | ARM-type_fold | USP34 SMG1 DOCK8 NEK10 DOCK9 RTTN USP9Y ECPAS VIRMA VAC14 MROH1 PSME4 CEBPZ PIK3CB PRKDC KPNA2 | 1.42e-07 | 339 | 176 | 16 | IPR016024 |
| Domain | ARM-like | SMG1 SETX DOCK8 NEK10 RTTN USP9Y ECPAS VAC14 MROH1 PSME4 PRKDC KPNA2 | 1.00e-05 | 270 | 176 | 12 | IPR011989 |
| Domain | P-loop_NTPase | ERCC3 SETX THNSL1 DIRAS1 DNAH10 MYO1E MYO9A DYNC2H1 MYO9B CFTR AK9 DDX1 NLRP10 NPHP3 TRANK1 CIITA SBNO1 RASL11A EIF5B ABCC2 RAP2C | 5.09e-05 | 848 | 176 | 21 | IPR027417 |
| Domain | HEAT_REPEAT | 5.12e-05 | 70 | 176 | 6 | PS50077 | |
| Domain | DUOX1 | 8.83e-05 | 2 | 176 | 2 | IPR029595 | |
| Domain | Vac14_Fab1-bd | 8.83e-05 | 2 | 176 | 2 | IPR032878 | |
| Domain | Vac14_Fab1_bd | 8.83e-05 | 2 | 176 | 2 | PF12755 | |
| Domain | Alkaline_phosphatase_core | 1.97e-04 | 31 | 176 | 4 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 1.97e-04 | 31 | 176 | 4 | IPR017849 | |
| Domain | - | 1.97e-04 | 31 | 176 | 4 | 3.40.720.10 | |
| Domain | - | ERCC3 SETX THNSL1 DIRAS1 DNAH10 MYO1E DYNC2H1 CFTR AK9 DDX1 NLRP10 NPHP3 TRANK1 SBNO1 RASL11A EIF5B ABCC2 RAP2C | 2.48e-04 | 746 | 176 | 18 | 3.40.50.300 |
| Domain | Amidase | 2.63e-04 | 3 | 176 | 2 | IPR000120 | |
| Domain | FerA | 2.63e-04 | 3 | 176 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 2.63e-04 | 3 | 176 | 2 | IPR012560 | |
| Domain | - | 2.63e-04 | 3 | 176 | 2 | 3.90.1300.10 | |
| Domain | AMIDASES | 2.63e-04 | 3 | 176 | 2 | PS00571 | |
| Domain | Amidase_dom | 2.63e-04 | 3 | 176 | 2 | IPR023631 | |
| Domain | FerA | 2.63e-04 | 3 | 176 | 2 | PF08165 | |
| Domain | Amidase | 2.63e-04 | 3 | 176 | 2 | PF01425 | |
| Domain | PI3/4_kinase_CS | 3.44e-04 | 15 | 176 | 3 | IPR018936 | |
| Domain | - | 4.21e-04 | 16 | 176 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.21e-04 | 16 | 176 | 3 | SM00146 | |
| Domain | DysFC | 5.23e-04 | 4 | 176 | 2 | SM00694 | |
| Domain | DysFN | 5.23e-04 | 4 | 176 | 2 | SM00693 | |
| Domain | Peroxin/Ferlin | 5.23e-04 | 4 | 176 | 2 | IPR006614 | |
| Domain | PI3_PI4_kinase | 6.05e-04 | 18 | 176 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.05e-04 | 18 | 176 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.05e-04 | 18 | 176 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.05e-04 | 18 | 176 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 6.05e-04 | 18 | 176 | 3 | PS50290 | |
| Domain | Fd_Rdtase_FAD-bd | 7.13e-04 | 19 | 176 | 3 | IPR017927 | |
| Domain | FAD_FR | 7.13e-04 | 19 | 176 | 3 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 7.13e-04 | 19 | 176 | 3 | IPR017938 | |
| Domain | FerI | 8.67e-04 | 5 | 176 | 2 | SM01202 | |
| Domain | FerB | 8.67e-04 | 5 | 176 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 8.67e-04 | 5 | 176 | 2 | IPR012561 | |
| Domain | Ferlin_C | 8.67e-04 | 5 | 176 | 2 | PF16165 | |
| Domain | Ferlin_C | 8.67e-04 | 5 | 176 | 2 | IPR032362 | |
| Domain | FerIin_dom | 8.67e-04 | 5 | 176 | 2 | IPR012968 | |
| Domain | FerI | 8.67e-04 | 5 | 176 | 2 | PF08151 | |
| Domain | FerB | 8.67e-04 | 5 | 176 | 2 | PF08150 | |
| Domain | FATC | 8.67e-04 | 5 | 176 | 2 | PF02260 | |
| Domain | C2_dom | 9.42e-04 | 164 | 176 | 7 | IPR000008 | |
| Domain | HEAT | 1.07e-03 | 48 | 176 | 4 | PF02985 | |
| Domain | - | 1.24e-03 | 222 | 176 | 8 | 1.25.10.10 | |
| Domain | DUF3398 | 1.29e-03 | 6 | 176 | 2 | PF11878 | |
| Domain | FAT | 1.29e-03 | 6 | 176 | 2 | PS51189 | |
| Domain | FATC | 1.29e-03 | 6 | 176 | 2 | PS51190 | |
| Domain | FATC_dom | 1.29e-03 | 6 | 176 | 2 | IPR003152 | |
| Domain | DOCK_C/D_N | 1.29e-03 | 6 | 176 | 2 | IPR021816 | |
| Domain | PIK_FAT | 1.29e-03 | 6 | 176 | 2 | IPR014009 | |
| Domain | FATC | 1.29e-03 | 6 | 176 | 2 | SM01343 | |
| Domain | C2 | 1.52e-03 | 131 | 176 | 6 | PF00168 | |
| Domain | E-NPP | 1.80e-03 | 7 | 176 | 2 | IPR024873 | |
| Domain | NAD_binding_6 | 1.80e-03 | 7 | 176 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.80e-03 | 7 | 176 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 1.80e-03 | 7 | 176 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.80e-03 | 7 | 176 | 2 | IPR013121 | |
| Domain | C2 | 1.91e-03 | 137 | 176 | 6 | SM00239 | |
| Domain | HECT | 2.04e-03 | 27 | 176 | 3 | PF00632 | |
| Domain | HECTc | 2.04e-03 | 27 | 176 | 3 | SM00119 | |
| Domain | HECT_dom | 2.04e-03 | 27 | 176 | 3 | IPR000569 | |
| Domain | AT_hook | 2.04e-03 | 27 | 176 | 3 | SM00384 | |
| Domain | HECT | 2.04e-03 | 27 | 176 | 3 | PS50237 | |
| Domain | AT_hook_DNA-bd_motif | 2.04e-03 | 27 | 176 | 3 | IPR017956 | |
| Domain | HEAT | 2.18e-03 | 58 | 176 | 4 | IPR000357 | |
| Domain | C2 | 2.29e-03 | 142 | 176 | 6 | PS50004 | |
| Domain | DHC_N1 | 2.38e-03 | 8 | 176 | 2 | PF08385 | |
| Domain | Helicase/UvrB_N | 2.38e-03 | 8 | 176 | 2 | IPR006935 | |
| Domain | ResIII | 2.38e-03 | 8 | 176 | 2 | PF04851 | |
| Domain | Dynein_heavy_dom-1 | 2.38e-03 | 8 | 176 | 2 | IPR013594 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | ERCC3 MYO9A RPN2 MYO9B NDUFA5 DDX1 PSME4 PPT1 NUP133 PRKDC KPNA2 | 1.44e-08 | 211 | 179 | 11 | 17314511 |
| Pubmed | SMG1 EPRS1 RPN2 CES1 ASH1L DUOX2 SPG11 NDUFA5 PFKP PLA2G4D NDUFAB1 DDX1 LIG4 C2CD3 SBNO1 CEBPZ DNAJA4 SYNE2 VPS13A EIF5B PRKDC PLEC ABCC2 CADPS2 PCK1 PHTF1 | 2.83e-08 | 1442 | 179 | 26 | 35575683 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 RPN2 DYNC2H1 ASH1L RPS16 PFKP ECPAS DDX1 GSTZ1 NBAS MYOF DUOX1 NT5C2 EIF5B RBM46 PRKDC PLEC CAP1 | 2.21e-07 | 807 | 179 | 18 | 30575818 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 ERCC3 SETX MYO9A MYO9B ADNP2 RPS16 PFKP DDX1 GSTZ1 EIF2D KARS1 SUGT1 PSME4 VPS33B CEBPZ PLEKHG3 NUP133 SMU1 EIF5B PRKDC PLEC CAP1 | 5.39e-07 | 1353 | 179 | 23 | 29467282 |
| Pubmed | USP34 GALNS MYO9A DYNC2H1 NAP1L5 MPDZ ADCY3 KMT2C PSME4 SYNE2 PRKDC | 1.01e-06 | 322 | 179 | 11 | 26514267 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.14e-06 | 202 | 179 | 9 | 33005030 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 DIRAS1 MYO1E MYO9B DOCK9 UBE3B RTTN PLEKHG5 CCNE1 KANSL3 KMT2C MYOF VAC14 C2CD3 WIZ MROH1 PSME4 PRKDC PLEC HERC1 | 1.22e-06 | 1105 | 179 | 20 | 35748872 |
| Pubmed | USP34 SMG1 MYO1E RPN2 NDUFA5 PFKP ECPAS DDX1 CCNE1 CNNM4 NBAS MYOF KARS1 SUGT1 CEBPZ PLEKHG3 SYNE2 SELENOF NUP133 SMU1 EIF5B PRKDC KPNA2 | 1.56e-06 | 1440 | 179 | 23 | 30833792 | |
| Pubmed | USP34 RPN2 RPS16 PFKP ECPAS VIRMA KARS1 CEBPZ SYNE2 NUP133 SMU1 EIF5B PRKDC PLEC CAP1 | 1.65e-06 | 653 | 179 | 15 | 22586326 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 EPRS1 MYO1E SWAP70 NAP1L5 RPS16 PFKP ECPAS DDX1 KARS1 SUGT1 PSME4 SBNO1 ATG3 NT5C2 NUP133 EIF5B PLCB3 PRKDC PLEC HERC1 CAP1 KPNA2 | 1.85e-06 | 1455 | 179 | 23 | 22863883 |
| Pubmed | LRRC8C EPRS1 ATP7A DOCK8 RPN2 MYO9B DOCK9 RPS16 ITGA4 PFKP ECPAS ADCY3 DDX1 NBAS PPT1 NUP133 ADAM17 PRKDC SLC25A17 KPNA2 | 2.82e-06 | 1168 | 179 | 20 | 19946888 | |
| Pubmed | USP34 EPRS1 SETX DOCK9 ASH1L FAM171B ADCY3 KMT2C NPHP3 EML5 PSME4 VPS33B FEZ2 FMN1 ADAM17 PLEC HERC1 RAP2C FHIP2B | 3.63e-06 | 1084 | 179 | 19 | 11544199 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ATP7A TRPM7 DOCK9 ITGA4 FAM171B ITGAV ADCY3 CNNM4 MYOF FMN1 GULP1 | 4.59e-06 | 377 | 179 | 11 | 38117590 |
| Pubmed | SMG1 EPRS1 SETX THNSL1 RPN2 UBE3B MPDZ PIAS1 DDX1 LIG4 EIF2D PSME4 PLCB3 SLC25A17 | 7.71e-06 | 650 | 179 | 14 | 38777146 | |
| Pubmed | 7.72e-06 | 193 | 179 | 8 | 19343046 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 ERCC3 MYO1E RPN2 LAMA3 RPS16 ITGA4 PFKP VIRMA DDX1 MYOF KARS1 CEBPZ PLEKHG3 NUP133 SMU1 EIF5B PRKDC PLEC KPNA2 | 8.33e-06 | 1257 | 179 | 20 | 36526897 |
| Pubmed | EPRS1 RPS16 PFKP ECPAS DDX1 KARS1 DNAJA4 NUP133 EIF5B PLEC CAP1 KPNA2 | 1.08e-05 | 494 | 179 | 12 | 26831064 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SETX DOCK8 PFKP DDX1 EIF2D WIZ SUGT1 VPS33B BRD7 PRKDC PLEC KPNA2 GULP1 | 1.12e-05 | 582 | 179 | 13 | 20467437 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.14e-05 | 268 | 179 | 9 | 33024031 | |
| Pubmed | USP34 EPRS1 MYO1E TRPM7 ASH1L NR4A2 ADNP2 NAP1L2 USP9Y PIAS1 BRWD3 NPRL2 WIZ PPT1 SBNO1 ENPP5 PRKDC PLEC CADPS2 MBD4 | 1.15e-05 | 1285 | 179 | 20 | 35914814 | |
| Pubmed | 1.48e-05 | 277 | 179 | 9 | 30745168 | ||
| Pubmed | EPRS1 RPS16 NDUFA5 ITGA4 PFKP ECPAS ITGAV DDX1 KARS1 EIF5B PRKDC PLEC CAP1 KPNA2 | 1.96e-05 | 707 | 179 | 14 | 19738201 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.99e-05 | 220 | 179 | 8 | 35785414 | |
| Pubmed | USP34 SMG1 GGA2 SETX SPG11 ECPAS PLEKHG5 KANSL3 KMT2C KARS1 TRANK1 PSME4 | 2.11e-05 | 529 | 179 | 12 | 14621295 | |
| Pubmed | USP34 ERCC3 PFKP ECPAS PIAS1 VIRMA DDX1 KANSL3 KARS1 SBNO1 ATG3 NUP133 SMU1 EIF5B PRKDC PLEC MBD4 | 2.14e-05 | 1014 | 179 | 17 | 32416067 | |
| Pubmed | LRCH2 MYO9A DOCK8 RPN2 DOCK9 FASTKD1 MPDZ NDUFA5 ECPAS PLEKHG5 VIRMA SUGT1 PLEKHG3 NT5C2 PLEC KPNA2 | 2.31e-05 | 916 | 179 | 16 | 32203420 | |
| Pubmed | EPRS1 ERCC3 RPN2 MYO9B RPS16 NDUFA5 PFKP DDX1 MYOF NPRL2 EIF2D SUGT1 PPT1 CEBPZ SMU1 EIF5B PRKDC CAP1 KPNA2 | 2.57e-05 | 1247 | 179 | 19 | 27684187 | |
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 2.63e-05 | 2 | 179 | 2 | 28633507 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 34884866 | ||
| Pubmed | SLC26A9 stimulates CFTR expression and function in human bronchial cell lines. | 2.63e-05 | 2 | 179 | 2 | 20658517 | |
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 2.63e-05 | 2 | 179 | 2 | 22523549 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 2.63e-05 | 2 | 179 | 2 | 23281318 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 36939278 | ||
| Pubmed | Developmental expression of canalicular transporter genes in human liver. | 2.63e-05 | 2 | 179 | 2 | 15922475 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23362256 | ||
| Pubmed | Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. | 2.63e-05 | 2 | 179 | 2 | 11822874 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18177232 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24962344 | ||
| Pubmed | Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. | 2.63e-05 | 2 | 179 | 2 | 12824283 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18285341 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 26993601 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21846720 | ||
| Pubmed | Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. | 2.63e-05 | 2 | 179 | 2 | 24161126 | |
| Pubmed | CD133 Regulates IL-1β Signaling and Neutrophil Recruitment in Glioblastoma. | 2.63e-05 | 2 | 179 | 2 | 28736425 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 19643730 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16111680 | ||
| Pubmed | Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. | 2.63e-05 | 2 | 179 | 2 | 11753072 | |
| Pubmed | Regulated hydrogen peroxide production by Duox in human airway epithelial cells. | 2.63e-05 | 2 | 179 | 2 | 15677770 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24128054 | ||
| Pubmed | MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. | 2.63e-05 | 2 | 179 | 2 | 16081800 | |
| Pubmed | Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins. | 2.63e-05 | 2 | 179 | 2 | 37686084 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24965066 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 31706280 | ||
| Pubmed | Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. | 2.63e-05 | 2 | 179 | 2 | 15972824 | |
| Pubmed | SWAP-70 regulates erythropoiesis by controlling α4 integrin. | 2.63e-05 | 2 | 179 | 2 | 21880631 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 19144650 | ||
| Pubmed | Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer. | 2.63e-05 | 2 | 179 | 2 | 20503398 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11762710 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25713392 | ||
| Pubmed | Proteasome-Associated Proteins, PA200 and ECPAS, Are Essential for Murine Spermatogenesis. | 2.63e-05 | 2 | 179 | 2 | 37189334 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 31645438 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24456163 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16099848 | ||
| Pubmed | Congenital Hypothyroidism due to Oligogenic Mutations in Two Sudanese Families. | 2.63e-05 | 2 | 179 | 2 | 30375286 | |
| Pubmed | Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. | 2.63e-05 | 2 | 179 | 2 | 10806195 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11514595 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 32451867 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11443211 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 10601291 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22384041 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 29797489 | ||
| Pubmed | SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. | 2.63e-05 | 2 | 179 | 2 | 19289574 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18508926 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23417678 | ||
| Pubmed | Epigenetic control of alternative mRNA processing at the imprinted Herc3/Nap1l5 locus. | 2.63e-05 | 2 | 179 | 2 | 22790983 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25586178 | ||
| Pubmed | Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. | 2.63e-05 | 2 | 179 | 2 | 18281478 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 15062544 | ||
| Pubmed | EPRS1 RPN2 RPS16 ECPAS DDX1 KARS1 NUP133 SMU1 EIF5B PRKDC PLEC CAP1 KPNA2 | 2.92e-05 | 638 | 179 | 13 | 33239621 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LRRC8C EPRS1 SETX RPS16 SLC26A9 PFKP ECPAS KMT2C KARS1 WIZ VPS13A PLCB3 RXFP1 PRKDC | 3.05e-05 | 736 | 179 | 14 | 29676528 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 MYO1E RPN2 RPS16 NDUFA5 PFKP DDX1 MRM3 KARS1 SBNO1 CEBPZ DNAJA4 SYNE2 SELENOF SMU1 EIF5B PLCB3 PRKDC PLEC KPNA2 | 4.48e-05 | 1415 | 179 | 20 | 28515276 |
| Pubmed | 4.68e-05 | 14 | 179 | 3 | 9373155 | ||
| Pubmed | 4.68e-05 | 14 | 179 | 3 | 8022818 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 DNAH10 RPN2 DYNC2H1 KIAA0586 RPS16 DUOX2 ECPAS DDX1 MRM3 KARS1 VPS33B SBNO1 CEBPZ NUP133 SMU1 EIF5B PRKDC CAP1 KPNA2 | 4.94e-05 | 1425 | 179 | 20 | 30948266 |
| Pubmed | 5.08e-05 | 251 | 179 | 8 | 29778605 | ||
| Pubmed | 5.53e-05 | 187 | 179 | 7 | 26460568 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 6.20e-05 | 333 | 179 | 9 | 32665550 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | EPRS1 LCORL RPN2 MYO9B TXNIP KMT2C NPRL2 KARS1 WIZ VPS33B CEBPZ PIK3CB SYNE2 SELENOF HERC3 MBD4 QRSL1 | 7.64e-05 | 1124 | 179 | 17 | 21900206 |
| Pubmed | Phosphorylation and regulation of DNA ligase IV stability by DNA-dependent protein kinase. | 7.88e-05 | 3 | 179 | 2 | 15194694 | |
| Pubmed | Identification of novel hub genes associated with liver metastasis of gastric cancer. | 7.88e-05 | 3 | 179 | 2 | 19569046 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 21915726 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 22386318 | ||
| Pubmed | Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. | 7.88e-05 | 3 | 179 | 2 | 9259561 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 20685652 | ||
| Pubmed | Interaction of the Ku heterodimer with the DNA ligase IV/Xrcc4 complex and its regulation by DNA-PK. | 7.88e-05 | 3 | 179 | 2 | 17241822 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 26858253 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 30692915 | ||
| Pubmed | Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection. | 7.88e-05 | 3 | 179 | 2 | 25500839 | |
| Pubmed | NADPH oxidase-dependent acid production in airway epithelial cells. | 7.88e-05 | 3 | 179 | 2 | 15210697 | |
| Pubmed | DUOX enzyme activity promotes AKT signalling in prostate cancer cells. | 7.88e-05 | 3 | 179 | 2 | 23225414 | |
| GeneFamily | Myosins, class IX | 4.15e-05 | 2 | 117 | 2 | 1103 | |
| GeneFamily | Ferlin family | 6.12e-04 | 6 | 117 | 2 | 828 | |
| GeneFamily | RAS type GTPase family | 1.04e-03 | 31 | 117 | 3 | 389 | |
| GeneFamily | Serpin peptidase inhibitors | 1.75e-03 | 37 | 117 | 3 | 739 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 GGA2 ATP7A TRPM7 LCORL ASH1L KMT2C CIBAR1 SYNE2 PLEC HERC1 CDH2 GULP1 | 5.27e-07 | 275 | 176 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 1.36e-06 | 67 | 176 | 7 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | USP34 SMG1 ATP7A TRPM7 LCORL MYO9A KIAA0586 ASH1L KMT2C CLCA1 EML5 SBNO1 DNAJA4 ZNF43 CIBAR1 SYNE2 RBM46 PLEC HERC1 RNF182 FHIP2B | 2.87e-06 | 795 | 176 | 21 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | DIRAS1 SPATA6 DYNC2H1 KIAA0586 NR4A2 MDGA2 CASTOR2 FAM171B TFDP2 GSTZ1 PROM1 C2CD3 EML5 ZNF43 PIK3CB CIBAR1 SYNE2 NT5C2 HERC3 CDH2 PHTF1 EPHA5 | 5.03e-06 | 893 | 176 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-05 | 127 | 176 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SMG1 SETX TRPM7 CFTR NAP1L5 ASH1L NAP1L2 ITGA4 FAM171B ECPAS PIAS1 CLCA1 EML5 SBNO1 CNTNAP4 RXFP1 CDH2 RNF182 EPHA5 GULP1 | 1.56e-05 | 818 | 176 | 20 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.64e-05 | 97 | 176 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | SMG1 ATP7A TRPM7 KIAA0586 ASH1L ZNF43 CIBAR1 SYNE2 PLEC FHIP2B | 2.31e-05 | 230 | 176 | 10 | gudmap_developingGonad_e16.5_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 3.10e-05 | 107 | 176 | 7 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | USP34 NAP1L5 NR4A2 NAP1L2 ITGA4 ITGAV PIAS1 BRWD3 RAP2C CDH2 RNF182 GULP1 | 3.63e-05 | 349 | 176 | 12 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | GGA2 ATP7A TRPM7 LCORL KIAA0586 ASH1L NAP1L2 BRWD3 CLCA1 ZNF43 CIBAR1 SYNE2 RBM46 ASB4 HERC1 CDH2 RNF182 FHIP2B GULP1 | 4.09e-05 | 804 | 176 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 7.53e-05 | 166 | 176 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | USP34 SMG1 ATP7A LCORL MYO9A ASH1L ECPAS KMT2C CLCA1 EML5 SBNO1 CIBAR1 SYNE2 VPS13A RBM46 HERC3 HERC1 RNF182 | 8.34e-05 | 776 | 176 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | GGA2 TRPM7 KIAA0586 ASH1L FAM171B ZNF43 SYNE2 HERC1 CDH2 FHIP2B GULP1 | 8.40e-05 | 323 | 176 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_500 | 1.02e-04 | 129 | 176 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.04e-04 | 90 | 176 | 6 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | GGA2 ATP7A TRPM7 KIAA0586 ASH1L ZNF43 SYNE2 CDH2 FHIP2B GULP1 | 1.10e-04 | 277 | 176 | 10 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SMG1 GGA2 ATP7A TRPM7 LCORL ASH1L ITGA4 KMT2C PIEZO2 ZNF43 CIBAR1 SYNE2 RBM46 PLEC HERC1 CDH2 RNF182 GULP1 | 1.24e-04 | 801 | 176 | 18 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SMG1 ATP7A TRPM7 LCORL KIAA0586 ASH1L CLCA1 PPT1 SBNO1 CIBAR1 SYNE2 EIF5B RBM46 ASB4 PLEC HERC1 CDH2 RNF182 | 1.34e-04 | 806 | 176 | 18 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | GGA2 ATP7A TRPM7 LCORL KIAA0586 ASH1L NAP1L2 FAM171B BRWD3 ZNF43 CIBAR1 SYNE2 ASB4 HERC1 CDH2 RNF182 FHIP2B GULP1 | 1.54e-04 | 815 | 176 | 18 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SMG1 SETX THNSL1 SWT1 MYO9A CCNE1 KMT2C TRANK1 EML5 VPS33B VPS13A NUP133 RBM46 HERC3 PRKDC HERC1 RNF182 PHTF1 | 1.66e-04 | 820 | 176 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 1.78e-04 | 188 | 176 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EPRS1 SWT1 MYO9A DYNC2H1 KIAA0586 ASH1L NR4A2 MDGA2 VIRMA PROM1 EML5 CEBPZ SYNE2 VPS13A NT5C2 PRKDC CDH2 EPHA5 | 1.95e-04 | 831 | 176 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | SETX LRCH2 HYKK NAP1L5 NAP1L2 ITGA4 FAM171B ITGAV CCNE1 KARS1 CLCA1 FEZ2 NUP133 RBM46 ASB4 CDH2 RNF182 GULP1 | 2.13e-04 | 837 | 176 | 18 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | SETX NAP1L5 NR4A2 NAP1L2 ITGA4 PIAS1 BRWD3 CLCA1 RBM46 ASB4 CDH2 GULP1 | 2.18e-04 | 422 | 176 | 12 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_500 | 2.18e-04 | 36 | 176 | 4 | gudmap_developingGonad_P2_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | SETX CFTR NAP1L5 NAP1L2 FAM171B CLCA1 EML5 CNTNAP4 RXFP1 RNF182 EPHA5 GULP1 | 2.43e-04 | 427 | 176 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.59e-04 | 150 | 176 | 7 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | USP34 ATP7A TRPM7 LCORL DOCK9 ASH1L TXNIP KMT2C SBNO1 DNAJA4 CIBAR1 SYNE2 RBM46 HERC3 PLEC HERC1 FHIP2B | 2.67e-04 | 778 | 176 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_200 | 2.71e-04 | 69 | 176 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_500 | 2.89e-04 | 70 | 176 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.75e-04 | 74 | 176 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 3.91e-04 | 266 | 176 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | SETX THNSL1 SWAP70 SWT1 KIAA0586 PIPOX PFKP CCNE1 VAC14 PIK3CB VPS13A NUP133 RBM46 HERC3 PRKDC RNF182 KPNA2 | 5.01e-04 | 822 | 176 | 17 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 5.21e-04 | 45 | 176 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | ATP7A TRPM7 LCORL ASH1L CLCA1 CIBAR1 SYNE2 RBM46 ASB4 HERC1 RNF182 | 5.61e-04 | 403 | 176 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | 5.69e-04 | 81 | 176 | 5 | GSM538260_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 5.69e-04 | 81 | 176 | 5 | GSM538234_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | EPRS1 DIRAS1 DYNC2H1 KIAA0586 NR4A2 MDGA2 CNNM4 PROM1 VAC14 EML5 CEBPZ PIK3CB SYNE2 VPS13A NT5C2 PRKDC CDH2 PHTF1 EPHA5 | 5.77e-04 | 989 | 176 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SMG1 ATP7A TRPM7 LCORL ASH1L ITGA4 CIBAR1 SYNE2 RBM46 HERC1 CDH2 | 6.87e-04 | 413 | 176 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | LRRC8C SPATA6 MYO1E SWAP70 LCORL DOCK8 DOCK9 NR4A2 MDGA2 PFKP PROM1 PIEZO2 CLCA1 PIK3CB ASB4 IL1B GULP1 | 7.00e-04 | 847 | 176 | 17 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 7.25e-04 | 178 | 176 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 7.26e-04 | 232 | 176 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.30e-04 | 129 | 176 | 6 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_500 | 7.49e-04 | 86 | 176 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 7.89e-04 | 87 | 176 | 5 | GSM538255_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | 8.23e-04 | 132 | 176 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | NAP1L5 NR4A2 NAP1L2 ITGA4 FAM171B CNTNAP4 ASB4 RXFP1 RNF182 EPHA5 GULP1 | 8.52e-04 | 424 | 176 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | DIRAS1 DNAH10 MDGA2 FAM171B TFDP2 PROM1 EML5 ZNF43 SYNE2 CNTNAP4 EIF5B CDH2 | 8.69e-04 | 493 | 176 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 8.75e-04 | 89 | 176 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 8.77e-04 | 23 | 176 | 3 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_500 | 8.77e-04 | 23 | 176 | 3 | gudmap_developingKidney_e15.5_Endothelial cells_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SMG1 GGA2 ATP7A TRPM7 LCORL ASH1L ITGA4 FAM171B KMT2C ZNF43 CIBAR1 SYNE2 RBM46 PLEC HERC1 RNF182 | 9.16e-04 | 790 | 176 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | SMG1 LRCH2 NAP1L2 ITGA4 FAM171B PIEZO2 ARSB SORCS2 CNTNAP4 RBM46 CADPS2 CDH2 KAT14 CACNA2D3 EPHA5 GULP1 | 9.28e-04 | 791 | 176 | 16 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | SPATA6 DNAH10 CES1 DYNC2H1 CFTR SERPINF1 MPDZ DNAJA4 ENPP5 CADPS2 GULP1 | 5.28e-10 | 198 | 179 | 11 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 |
| ToppCell | URO-Myeloid-cDC2|URO / Disease, Lineage and Cell Type | 1.10e-07 | 197 | 179 | 9 | 7fee14356d7fba68a0515c8b9284568d14124b0a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-07 | 200 | 179 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Sepsis-URO-Myeloid-cDC2|URO / Disease, condition lineage and cell class | 1.25e-07 | 200 | 179 | 9 | 4f696dc68a8ceec9a6e6293c6f6f878b321b0b6d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.14e-07 | 162 | 179 | 8 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.96e-07 | 186 | 179 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-06 | 193 | 179 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-06 | 193 | 179 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 194 | 179 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-06 | 198 | 179 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.49e-06 | 199 | 179 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.49e-06 | 199 | 179 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.54e-06 | 200 | 179 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-06 | 176 | 179 | 7 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-06 | 177 | 179 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.31e-06 | 118 | 179 | 6 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 8.80e-06 | 181 | 179 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 184 | 179 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 184 | 179 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 184 | 179 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.80e-06 | 184 | 179 | 7 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.01e-05 | 185 | 179 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.13e-05 | 188 | 179 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.17e-05 | 189 | 179 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 191 | 179 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.29e-05 | 192 | 179 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.29e-05 | 192 | 179 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 192 | 179 | 7 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 192 | 179 | 7 | 03acd4a26b986e34eee608747347791122f1aa52 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-05 | 192 | 179 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 192 | 179 | 7 | 31c6046589e2fbb0486fd044c5b128099d37872f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-05 | 193 | 179 | 7 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.34e-05 | 193 | 179 | 7 | 725326d7e3604736b607c19f4069c81cb4f2d20c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 193 | 179 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.43e-05 | 195 | 179 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.43e-05 | 195 | 179 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.43e-05 | 195 | 179 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 1.43e-05 | 195 | 179 | 7 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-05 | 130 | 179 | 6 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.48e-05 | 196 | 179 | 7 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 196 | 179 | 7 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.52e-05 | 197 | 179 | 7 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.52e-05 | 197 | 179 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-05 | 197 | 179 | 7 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 197 | 179 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.68e-05 | 200 | 179 | 7 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.68e-05 | 200 | 179 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.68e-05 | 200 | 179 | 7 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.68e-05 | 200 | 179 | 7 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.68e-05 | 200 | 179 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | (06)_Krt4/13+-(2)_48hpi|(06)_Krt4/13+ / shred by cell type and Timepoint | 1.98e-05 | 40 | 179 | 4 | 1e42cd186ee06ac9345e16ede649a72c15bdf2f8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-05 | 140 | 179 | 6 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.63e-05 | 153 | 179 | 6 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.63e-05 | 153 | 179 | 6 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-05 | 155 | 179 | 6 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.04e-05 | 156 | 179 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.04e-05 | 156 | 179 | 6 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl-Cadm2_(Layer_2/3,_Cadm2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.11e-05 | 48 | 179 | 4 | bbfc33299ea8e6895dd4d21a7dd38bec33563127 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-05 | 158 | 179 | 6 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 160 | 179 | 6 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 160 | 179 | 6 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.82e-05 | 161 | 179 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.99e-05 | 162 | 179 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 163 | 179 | 6 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 163 | 179 | 6 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 163 | 179 | 6 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.52e-05 | 165 | 179 | 6 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.91e-05 | 167 | 179 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-05 | 169 | 179 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-05 | 171 | 179 | 6 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 172 | 179 | 6 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.95e-05 | 172 | 179 | 6 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | droplet-Limb_Muscle-nan-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 172 | 179 | 6 | 770e4c5467ef2eaddf883723fb0aa1226973b000 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.65e-05 | 175 | 179 | 6 | 8269721389a3ce98681460e6393f2cff816eaa25 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-05 | 176 | 179 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-05 | 177 | 179 | 6 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-05 | 177 | 179 | 6 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 8.15e-05 | 177 | 179 | 6 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.15e-05 | 177 | 179 | 6 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.15e-05 | 177 | 179 | 6 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.67e-05 | 179 | 179 | 6 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.94e-05 | 180 | 179 | 6 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.94e-05 | 180 | 179 | 6 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-05 | 180 | 179 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-05 | 182 | 179 | 6 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.49e-05 | 182 | 179 | 6 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.49e-05 | 182 | 179 | 6 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.49e-05 | 182 | 179 | 6 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.49e-05 | 182 | 179 | 6 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 9.78e-05 | 183 | 179 | 6 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 1.01e-04 | 184 | 179 | 6 | 09fa465d1852b9b7e0405c27d4e5de276c9ba871 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-04 | 184 | 179 | 6 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.01e-04 | 184 | 179 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 184 | 179 | 6 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 184 | 179 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-CD4-naive_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.01e-04 | 184 | 179 | 6 | 00db55970d336a301035efe43a4ab4db62627f38 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 185 | 179 | 6 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 185 | 179 | 6 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 185 | 179 | 6 | eb338fcda0b237c2e0b9b4b0daf51febbfe1d79c | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 185 | 179 | 6 | c31bb53852caf36964b83b28bcaee07b679da779 | |
| Drug | PB-4 | 2.92e-07 | 35 | 179 | 6 | CID005289110 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.88e-06 | 191 | 179 | 10 | 1059_DN | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; HL60; HG-U133A | GGA2 SETX SWAP70 KIAA0586 ITGA4 MYOF PSME4 DNAJA4 MBD4 DMAC2L | 3.47e-06 | 195 | 179 | 10 | 1762_DN |
| Disease | reticulocyte count | USP34 EPRS1 DNAH10 SWAP70 LCORL MYO9B CYP27A1 ASH1L LAMA3 PEX12 ITGA4 ADCY3 DNAJA4 DNAH17 SYNE2 VPS13A NT5C2 PLCB3 HERC1 MMP13 | 3.62e-06 | 1045 | 173 | 20 | EFO_0007986 |
| Disease | Polydactyly | 6.80e-05 | 117 | 173 | 6 | C0152427 | |
| Disease | uric acid measurement | LRRC8C USP34 DCDC1 TRPM7 SWT1 MYO9A DYNC2H1 DDX1 TFDP2 MYOF SLC10A1 FMN1 CACNA2D3 | 6.84e-05 | 610 | 173 | 13 | EFO_0004761 |
| Disease | Saldino-Noonan Syndrome | 6.88e-05 | 14 | 173 | 3 | C0036069 | |
| Disease | reticulocyte measurement | USP34 DNAH10 SWAP70 LCORL MYO9B ASH1L PEX12 ITGA4 ECPAS ADCY3 WIZ DNAJA4 DNAH17 SYNE2 VPS13A NT5C2 PLCB3 | 1.63e-04 | 1053 | 173 | 17 | EFO_0010700 |
| Disease | phenylketonuria (implicated_via_orthology) | 2.03e-04 | 4 | 173 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.26e-04 | 447 | 173 | 10 | C3714756 | |
| Disease | liver cancer (biomarker_via_orthology) | 3.38e-04 | 5 | 173 | 2 | DOID:3571 (biomarker_via_orthology) | |
| Disease | Arsenic Induced Polyneuropathy | 4.88e-04 | 62 | 173 | 4 | C0751852 | |
| Disease | Arsenic Encephalopathy | 4.88e-04 | 62 | 173 | 4 | C0751851 | |
| Disease | Arsenic Poisoning | 4.88e-04 | 62 | 173 | 4 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 4.88e-04 | 62 | 173 | 4 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 4.88e-04 | 62 | 173 | 4 | C0274862 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 7.04e-04 | 7 | 173 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | erythrocyte measurement | 8.37e-04 | 257 | 173 | 7 | EFO_0005047 | |
| Disease | Todd Paralysis | 1.20e-03 | 9 | 173 | 2 | C0234544 | |
| Disease | Paralysed | 1.20e-03 | 9 | 173 | 2 | C0522224 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.20e-03 | 9 | 173 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.20e-03 | 9 | 173 | 2 | C0085548 | |
| Disease | Colorectal Neoplasms | 1.29e-03 | 277 | 173 | 7 | C0009404 | |
| Disease | Nephroblastoma | 1.49e-03 | 10 | 173 | 2 | Orphanet_654 | |
| Disease | Combined immunodeficiency | 1.79e-03 | 41 | 173 | 3 | C0494261 | |
| Disease | Seizures | 1.86e-03 | 218 | 173 | 6 | C0036572 | |
| Disease | nevus count, cutaneous melanoma | 2.05e-03 | 91 | 173 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | Herpes Zoster, response to tofacitinib | 2.17e-03 | 12 | 173 | 2 | EFO_0006510, EFO_0600024 | |
| Disease | Charcot-Marie-Tooth Disease | 2.17e-03 | 12 | 173 | 2 | C0007959 | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 2.17e-03 | 12 | 173 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 2.22e-03 | 93 | 173 | 4 | C1535926 | |
| Disease | hypertension | 2.31e-03 | 307 | 173 | 7 | EFO_0000537 | |
| Disease | urate measurement | USP34 DCDC1 MYO9A ASH1L SLC25A30 DDX1 TFDP2 CCNE1 FMN1 NT5C2 SMU1 PLCB3 HERC3 | 2.48e-03 | 895 | 173 | 13 | EFO_0004531 |
| Disease | obsolete_red blood cell distribution width | SWAP70 DOCK8 MYO9B UBE3B PEX12 DUOX2 AK9 PLEKHG5 CCNE1 NPRL2 VPS33B DNAJA4 SYNE2 VPS13A NT5C2 HERC1 RNF182 | 2.49e-03 | 1347 | 173 | 17 | EFO_0005192 |
| Disease | uveitis (is_implicated_in) | 2.55e-03 | 13 | 173 | 2 | DOID:13141 (is_implicated_in) | |
| Disease | Short Rib-Polydactyly Syndrome | 2.55e-03 | 13 | 173 | 2 | C0036996 | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.55e-03 | 13 | 173 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | Disease Exacerbation | 2.95e-03 | 165 | 173 | 5 | C0235874 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.97e-03 | 14 | 173 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | Majewski Syndrome | 2.97e-03 | 14 | 173 | 2 | C0024507 | |
| Disease | Colorectal Carcinoma | GALNS TRPM7 CFTR NR4A2 PROM1 KMT2C ZNF43 RASL11A VPS13A ABCC2 RNF182 | 2.99e-03 | 702 | 173 | 11 | C0009402 |
| Disease | cholestasis (biomarker_via_orthology) | 2.99e-03 | 49 | 173 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Generalized seizures | 3.00e-03 | 101 | 173 | 4 | C0234533 | |
| Disease | Clonic Seizures | 3.00e-03 | 101 | 173 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 3.00e-03 | 101 | 173 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 3.00e-03 | 101 | 173 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 3.00e-03 | 101 | 173 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 3.00e-03 | 101 | 173 | 4 | C0751123 | |
| Disease | Complex partial seizures | 3.00e-03 | 101 | 173 | 4 | C0149958 | |
| Disease | Single Seizure | 3.00e-03 | 101 | 173 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 3.00e-03 | 101 | 173 | 4 | C3495874 | |
| Disease | Visual seizure | 3.00e-03 | 101 | 173 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 3.00e-03 | 101 | 173 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 3.00e-03 | 101 | 173 | 4 | C0422855 | |
| Disease | Gustatory seizure | 3.00e-03 | 101 | 173 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 3.00e-03 | 101 | 173 | 4 | C0422850 | |
| Disease | Olfactory seizure | 3.00e-03 | 101 | 173 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 3.00e-03 | 101 | 173 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 3.00e-03 | 101 | 173 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 3.00e-03 | 101 | 173 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 3.00e-03 | 101 | 173 | 4 | C4317109 | |
| Disease | Absence Seizures | 3.10e-03 | 102 | 173 | 4 | C4316903 | |
| Disease | Convulsions | 3.10e-03 | 102 | 173 | 4 | C4048158 | |
| Disease | Tonic Seizures | 3.10e-03 | 102 | 173 | 4 | C0270844 | |
| Disease | Seizures, Focal | 3.33e-03 | 104 | 173 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 3.33e-03 | 104 | 173 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 3.33e-03 | 104 | 173 | 4 | C0494475 | |
| Disease | Adrenoleukodystrophy, Neonatal | 3.41e-03 | 15 | 173 | 2 | C0282525 | |
| Disease | posterior thigh muscle volume | 3.41e-03 | 15 | 173 | 2 | EFO_0020931 | |
| Disease | Rheumatoid Arthritis | 3.70e-03 | 174 | 173 | 5 | C0003873 | |
| Disease | Diabetic Angiopathies | 3.89e-03 | 16 | 173 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 3.89e-03 | 16 | 173 | 2 | C0025945 | |
| Disease | hip circumference | 3.92e-03 | 338 | 173 | 7 | EFO_0005093 | |
| Disease | Ciliopathies | 4.07e-03 | 110 | 173 | 4 | C4277690 | |
| Disease | Cholestasis | 4.07e-03 | 110 | 173 | 4 | C0008370 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.34e-03 | 112 | 173 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Amyotrophic lateral sclerosis | 4.39e-03 | 17 | 173 | 2 | cv:C0002736 | |
| Disease | cigarettes per day measurement | 4.47e-03 | 438 | 173 | 8 | EFO_0006525 | |
| Disease | brain aneurysm | 4.48e-03 | 113 | 173 | 4 | EFO_0003870 | |
| Disease | Malignant neoplasm of breast | ERCC3 WDR88 DYNC2H1 PKDREJ CCNE1 CNNM4 SBNO1 PIK3CB ANKEF1 SYNE2 NUP133 IL1B CDH2 RNF182 | 4.49e-03 | 1074 | 173 | 14 | C0006142 |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.59e-03 | 57 | 173 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | immature platelet fraction | 4.62e-03 | 114 | 173 | 4 | EFO_0009187 | |
| Disease | coronary artery disease | DNAH10 SWAP70 TRPM7 LCORL DOCK8 DYNC2H1 MYO9B DOCK9 UBE3B CFTR DUOX2 VPS33B ELFN1 NT5C2 MMP13 | 4.63e-03 | 1194 | 173 | 15 | EFO_0001645 |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 4.82e-03 | 58 | 173 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | forced expiratory volume, response to bronchodilator | 4.90e-03 | 445 | 173 | 8 | EFO_0004314, GO_0097366 | |
| Disease | matrix metalloproteinase 12 measurement | 4.92e-03 | 18 | 173 | 2 | EFO_0010590 | |
| Disease | nevus count | 4.92e-03 | 18 | 173 | 2 | EFO_0004632 | |
| Disease | non-alcoholic steatohepatitis (is_marker_for) | 4.92e-03 | 18 | 173 | 2 | DOID:0080547 (is_marker_for) | |
| Disease | progression free survival, ovarian carcinoma | 4.92e-03 | 18 | 173 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 4.92e-03 | 18 | 173 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | immature platelet measurement | 5.37e-03 | 119 | 173 | 4 | EFO_0803541 | |
| Disease | osteoporosis (implicated_via_orthology) | 5.47e-03 | 19 | 173 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | DNAH10 LCORL RPN2 MYO9B ADCY3 CCNE1 TRANK1 FEZ2 NFATC4 PLCB3 PLEC HERC1 SDR16C5 KPNA2 | 5.77e-03 | 1106 | 173 | 14 | EFO_0021796 |
| Disease | cystic fibrosis (is_marker_for) | 5.81e-03 | 62 | 173 | 3 | DOID:1485 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAKELIPEATEKYLG | 391 | P23141 | |
| LLEKIPGKNAIDVTY | 2931 | Q9NR48 | |
| LVPGKEELNIVKLYA | 41 | P41214 | |
| SLKKTIIELKYGPEL | 461 | P0C7U0 | |
| SVLPYALIKGIILRK | 321 | P13569 | |
| NLEKYVVKDGKLPLL | 221 | P49902 | |
| EEYVEKPLKLVLKVG | 16 | Q9NPI1 | |
| GEIKDKELPQYLALT | 726 | P33076 | |
| LSLKKYLLLEPEGII | 411 | Q9Y574 | |
| ELPVAIKTLKVGYTE | 701 | P54756 | |
| VLKLYDKIDPEKLSV | 86 | O14561 | |
| AKESIPLFTYGLIKL | 16 | A6NHX0 | |
| LFIAAKLEEIYPPKL | 196 | P24864 | |
| VVLLVVCGPLAYKKL | 391 | P06127 | |
| LAGPVAEYLKISKEI | 51 | Q01518 | |
| GLLAYKEHLPVTKIV | 751 | Q9C0A0 | |
| YDLPGILARLSKIKL | 151 | Q12887 | |
| YLLKICERIGPLLDK | 71 | Q6RI45 | |
| KQIEKLTKLGYPELI | 26 | Q9NU02 | |
| EYLELLSPVVRKLGV | 151 | Q4G176 | |
| IYKAPLEKGILIIQF | 311 | Q8WW22 | |
| KYLLLSDLPGVREKE | 181 | Q99766 | |
| DYLIKVLEKIPEGCT | 51 | Q8NCU1 | |
| EYKGNLLLKPIVEVA | 51 | Q6P9G0 | |
| KALEVAEYLTPVLKE | 11 | Q9NT62 | |
| ITILPKEKLGEREVY | 826 | Q6IQ32 | |
| QPKYLKLGAIDVERL | 241 | Q04656 | |
| YEKVPLILVGNKVDL | 106 | Q9Y3L5 | |
| DGKVLLVYKIVIPAI | 421 | Q8TBY0 | |
| YDEPILKLLTDIKVK | 261 | Q9ULW6 | |
| LLPILEPKYAVEKIV | 241 | Q8N3Y7 | |
| LILGITNPEGEKKYL | 266 | P35558 | |
| ADGYSLEILPKLKDV | 1201 | Q68DA7 | |
| TLLLKIPKEYDLVLL | 701 | Q9NRD9 | |
| QKLLKDGIQLSEYLP | 1106 | Q8WUM0 | |
| LYGRKIEDISKVPLL | 341 | M0R2J8 | |
| KIPVALGLKEKNLYL | 171 | P01584 | |
| VTEFIILGLTKKPEL | 6 | Q8NGZ3 | |
| TDGAILGKLYKIPEL | 1501 | Q8NEZ4 | |
| PTALLKLLKYIEVIS | 736 | Q8NG48 | |
| KAEGVLLDYLVLLPR | 851 | Q16787 | |
| GLIPVDLAELLISKY | 51 | Q86W26 | |
| LALYKKLLNVKPGLE | 811 | Q15034 | |
| KAGILYGIPQKTLLL | 296 | Q8N3X6 | |
| SKYAELLLIPKVLAE | 2526 | Q15751 | |
| LLLKIPKEYDLVLLF | 706 | Q9NRD8 | |
| KYIDNPKLRELLIIG | 311 | Q92499 | |
| YLGDIPLKTKEGAVL | 306 | Q5VYK3 | |
| VLLEIIKEEGLLAPY | 51 | O43808 | |
| QVKLYEGIPVLLSLL | 286 | Q6ZWH5 | |
| DPELLAYILEGKKIV | 166 | Q86V87 | |
| DILEGYPKKISELGL | 361 | P45452 | |
| ILGTKRVLPGKYLEE | 476 | Q01813 | |
| PVISDIDKKLGYLIQ | 206 | Q9UJA9 | |
| TPVSIYEEKLLLKRL | 461 | Q9H8E8 | |
| LTLTLQKKPLEVYHG | 696 | A0A1B0GTW7 | |
| FLNELIKVLSPKYLG | 106 | Q9UJY4 | |
| SIILKGYKRPLTLED | 211 | Q92887 | |
| LLPGILALYKKHAET | 266 | Q8NDA8 | |
| EYLVTLAKGDLKFPL | 956 | A2RRP1 | |
| KGELITYNLTELIKP | 696 | Q7Z553 | |
| LLYSSEKKIFIGLIP | 366 | Q86YD1 | |
| IKYGAVDPLLALLAV | 201 | P52292 | |
| LKPYITEGRITEKEI | 256 | Q96HP4 | |
| KDKVPYKGIVISLVL | 151 | Q14973 | |
| KIPGIYVLSLEIGKT | 61 | P50897 | |
| LEIGAKGKPYLTLEQ | 231 | Q01970 | |
| KQSLEELGPIYKLIV | 91 | O95057 | |
| ELGPIYKLIVQIKGS | 96 | O95057 | |
| EQLLPELLKKAGYVS | 121 | P34059 | |
| KRLYKETLEIEPILI | 3711 | Q8NCM8 | |
| PQLLYEIGKLAAKLD | 141 | A2RU49 | |
| PVYDITKKHLILSGL | 181 | Q5SVS4 | |
| YLLGVVKVPTKELLI | 1316 | Q4AC94 | |
| EVKVKIAALYLPLVG | 1206 | Q8NF50 | |
| VLLAKPKLIEPLDYE | 41 | Q9BZ29 | |
| KLYIELLNLPRDGKD | 91 | P49917 | |
| LEAKVVEPLKTYGTI | 91 | A1XBS5 | |
| TLKKGYGIPDLKIDL | 2826 | Q9UFH2 | |
| LADVSKLCIGIPKEY | 271 | Q9H0R6 | |
| KLCIGIPKEYLVPEL | 276 | Q9H0R6 | |
| EAIKLYLKGKEPLLQ | 671 | Q8IZS8 | |
| ELQISIYGVKILEPK | 71 | Q9UBP9 | |
| KIYIGDDNPLTLIVK | 646 | P06756 | |
| LKAVLKETLRLYPVV | 386 | Q02318 | |
| DGYKPLELLKITQEL | 371 | Q53R41 | |
| GIETYLIIASKPEVK | 486 | O60266 | |
| LALEDKELGRVILYP | 436 | Q86UW7 | |
| IPSIGLALLEEKLRY | 406 | Q6GMR7 | |
| ELLKPLGLYDLRAKT | 501 | O95243 | |
| RIALALKGIDYKTVP | 21 | O43708 | |
| HVKLPVGLYFIKILE | 676 | P13612 | |
| EKLLPQLLKEAGYTT | 126 | P15848 | |
| YLDALQTLKGKIPTL | 211 | Q9P2N6 | |
| KKRPIEDLVLELIFG | 1356 | Q05BV3 | |
| KIVDLNFLIGPKLYE | 476 | P19447 | |
| LLPKEGRLEKVYDAL | 286 | Q6UWV6 | |
| QPIALLKLLLEKGYL | 2536 | Q8IVF4 | |
| APDRKKLYSLLGIDL | 671 | A3KN83 | |
| LKIKFLEAGIYEVPI | 666 | P19022 | |
| GAVLIKVPYKLGLSL | 121 | Q6P995 | |
| LYLVSEILKAKPGLR | 606 | Q03701 | |
| EKVPSLLTDYILKVL | 336 | Q9UHY8 | |
| TLPKYLFDLPLKVLV | 171 | Q5VUJ6 | |
| KLVYKTGDVPLIRIE | 96 | Q9BZA8 | |
| KVLYDISEVLPGKLL | 106 | Q86XP0 | |
| YLSKLLGKLPELRTL | 551 | P43354 | |
| TKPLDICVKYLSGLL | 1286 | Q86VV8 | |
| DYLLPKDIKLAVLGA | 21 | Q6T310 | |
| ALIKKGIIPDLVIYL | 646 | Q5TCS8 | |
| DSGLYLKELIEPVLT | 86 | Q08AM6 | |
| VYEELLAIPVVKGRK | 1196 | P07814 | |
| GLKSTGKVIYVLVLL | 286 | Q9GZN6 | |
| LKVGPLDSVTYLDKI | 2546 | Q8WXH0 | |
| TKKGELSIIPYEITL | 191 | Q15046 | |
| KIKDYIIPDLLGGLS | 66 | Q7LBE3 | |
| LCDPYVILKLGKTEL | 1506 | A0AVI2 | |
| VVKLLGYSEKPLTLQ | 451 | Q14934 | |
| YLKELPVDKLKGVSL | 151 | Q9HC36 | |
| GKLDKAVPLYELAVE | 1191 | Q7Z494 | |
| VEDYLLKIIDTPGLL | 116 | A1L390 | |
| DIYKPLLAKIQELTG | 111 | Q96NT1 | |
| TLIQKKDFLPAGYLL | 696 | Q9NTG1 | |
| PLLVAYKEDEIPVLK | 946 | O60841 | |
| KNIPVLETAYKLILG | 556 | Q96Q15 | |
| PELDIEKTKLLYTAG | 1481 | Q96Q15 | |
| SKIDYDKPETVILGL | 86 | O43490 | |
| IPLKILKFSVDEGLT | 581 | Q96PQ0 | |
| TLQYKLLEPVLLLGK | 46 | P62249 | |
| YTSSVLEKGKLILLP | 211 | Q7Z333 | |
| APIDLLYELVKQKGL | 906 | O95785 | |
| SLPLGIYLLVSKKVT | 196 | Q8N6D2 | |
| IVKKLAGYLTTLELE | 101 | Q8WTW4 | |
| IKLQKLPFYDLLDEL | 136 | O75925 | |
| GLPELTSVKDIQYLK | 1011 | P42338 | |
| LEIKYELNSLLKPLG | 291 | Q96P15 | |
| ILKTTEVPGFDKLVL | 406 | Q5T5J6 | |
| ILYTKILDVLEEIPK | 26 | Q16718 | |
| VLLPYLKVKLEKLVS | 121 | O00623 | |
| LAKSLVPKALEGYIT | 336 | Q14188 | |
| YLKVDNEELLPKGLV | 186 | P78536 | |
| IRKKYPTDGSEIVLL | 396 | A8K7I4 | |
| IALGKYSPLEKEILR | 71 | Q5SQS8 | |
| SEKILLRLLKYPDVI | 571 | Q6P4Q7 | |
| KPKLLALGENYELLI | 101 | Q96JI7 | |
| YPLLLKSVLRKTEEP | 491 | O94827 | |
| IYGKLPLISLRISDK | 766 | Q96RL7 | |
| DEIPLVIKYKKAVGL | 396 | Q6ZMY6 | |
| IVVGYPIEKFISLLK | 1536 | O75970 | |
| VLTVPKLKLSYEGEV | 311 | P36955 | |
| LKLPDKTLIDLYEQV | 66 | Q2TAY7 | |
| KLLKELDTPFRLYGL | 711 | Q9UMS5 | |
| PKQIGEHLLLKSLTY | 196 | Q96AG3 | |
| LYLIIGDATLKNPIL | 481 | P04844 | |
| IKYVRGSDPVLKLLD | 121 | O60613 | |
| LDLLKLVKPYVKILE | 16 | O95073 | |
| GGDLLLKPIKSILRY | 1331 | Q9H5I5 | |
| YLVKLKSLSLEGIEI | 341 | Q9HBX9 | |
| KKNGIIVYLDVPLLD | 146 | Q8IYQ7 | |
| PYIAKILKGLEELEF | 266 | Q9UH36 | |
| KLPSGEDYNLKLELL | 211 | Q9Y2Z0 | |
| IDLLKEIYTNLGPRL | 791 | O00507 | |
| GYVIDPIKGLKLTVE | 4111 | Q15149 | |
| VLFIKLLYELVSIPK | 96 | Q14997 | |
| IPDTVLEKVYELLGL | 166 | P78527 | |
| PETKLILVDYILFKG | 226 | Q9UK55 | |
| GEKLYKPEDVTVILT | 786 | P17038 | |
| ILTGLTYLDDLLPKL | 481 | Q7Z3V4 | |
| FKLAPVVGKILYELS | 351 | Q9P0Z9 | |
| PLIIVSEEIEYLLKK | 131 | Q9UH65 | |
| KLLYALEIIEALGKP | 1436 | Q70CQ2 | |
| LVKLSVLVAYEGLPL | 3166 | Q70CQ2 | |
| KIPEELGLALVLTIY | 1551 | O15050 | |
| LLIYVSVPGSKKVIL | 276 | Q9H3M7 | |
| EIPSLIIKGLSYLQL | 406 | Q69YN4 | |
| PGVVLKDKEDIYLSI | 21 | Q9NWH7 | |
| LVPPAILLLEYKTKA | 766 | Q96QT4 | |
| LIYLLEQLPGKKDLF | 26 | Q9H267 | |
| KLAPKILEDIGLYLT | 1241 | Q9BVV6 | |
| PKIGNLLFLSYLDVK | 746 | Q8TDW0 | |
| KRDLLLTPKCLYLIG | 781 | Q12965 | |
| VTVGEKLILPYKLAE | 476 | B2RTY4 | |
| LISKKPTGLFYLLDE | 581 | Q13459 | |
| PYIKITLGKKVIEDR | 1576 | Q9NZM1 |